Results showed statistically significant reductions in body weight and body fat percentage in the AOD9604 treatment groups compared to placebo, with the highest dose producing average fat mass reductions of approximately 2.6 kg greater than placebo
This controlling/modulating angiogenesis [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40] and similar corresponding controlling/modulating NO-system functioning [11,29,92,93,94,97,98,99] occurred as particularities in BPC 157 therapy
View lab results AI Recommendations
Results showed 87.5% (14 of 16) experienced pain relief, with 91.6% responding to BPC-157 alone without additional treatments